APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,639,291 | +47.3% | 105,810 | +6.7% | 0.17% | +73.0% |
| Q1 2023 | $6,543,892 | +117.0% | 99,210 | +70.1% | 0.10% | +170.3% |
| Q4 2022 | $3,015,210 | -88.5% | 58,310 | -84.8% | 0.04% | -88.2% |
| Q3 2022 | $26,132,000 | +540.0% | 382,600 | +323.7% | 0.31% | +552.1% |
| Q2 2022 | $4,083,000 | +66.7% | 90,300 | +87.3% | 0.05% | +84.6% |
| Q1 2022 | $2,449,000 | -40.2% | 48,200 | -44.3% | 0.03% | -39.5% |
| Q4 2021 | $4,094,000 | +343.6% | 86,600 | +209.3% | 0.04% | +377.8% |
| Q3 2021 | $923,000 | – | 28,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |